Trial Profile
Effects of risedronic acid for the prevention and treatment of corticosteroid induced osteoporosis in postmenopausal women with rheumatoid arthritis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- 12 Dec 2015 New trial record